SG Americas Securities
TXG icon

SG Americas Securities’s 10x Genomics TXG Stock Holding History

SG Americas Securities’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Buy
115,208
+77,074
+202% +$2.02M ﹤0.01% 1147
2026
Q1 		$810K Sell
38,134
-25,633
-40% -$512K ﹤0.01% 1903
2025
Q4 		$1.04M Buy
63,767
+23,968
+60% +$362K ﹤0.01% 1979
2025
Q3 		$465K Sell
39,799
-40,241
-50% -$525K ﹤0.01% 2174
2025
Q2 		$927K Sell
80,040
-2,366
-3% -$21.6K ﹤0.01% 1227
2025
Q1 		$719K Buy
82,406
+9,360
+13% +$118K ﹤0.01% 1469
2024
Q4 		$1.05M Buy
73,046
+49,468
+210% +$781K ﹤0.01% 847
2024
Q3 		$532K Sell
23,578
-77,766
-77% -$1.61M ﹤0.01% 1637
2024
Q2 		$1.97M Buy
101,344
+86,967
+605% +$2.28M 0.01% 958
2024
Q1 		$540K Buy
+14,377
New +$632K ﹤0.01% 1389
2023
Q4 		– Sell
-64,162
Closed -$2.65M – 3457
2023
Q3 		$2.65M Buy
64,162
+43,070
+204% +$2.24M 0.03% 576
2023
Q2 		$1.18M Buy
21,092
+4,135
+24% +$224K 0.01% 974
2023
Q1 		$946K Sell
16,957
-11,600
-41% -$542K 0.01% 1174
2022
Q4 		$1.04M Sell
28,557
-2,943
-9% -$96.2K 0.01% 940
2022
Q3 		$897K Sell
31,500
-18,748
-37% -$714K 0.01% 1091
2022
Q2 		$2.27M Buy
50,248
+47,047
+1,470% +$2.44M 0.02% 670
2022
Q1 		$244K Buy
+3,201
New +$280K ﹤0.01% 2306
2021
Q4 		– Sell
-26,116
Closed -$3.8M – 3817
2021
Q3 		$3.8M Sell
26,116
-3,019
-10% -$518K 0.02% 727
2021
Q2 		$5.71M Buy
29,135
+23,777
+444% +$4.3M 0.03% 538
2021
Q1 		$970K Sell
5,358
-23,873
-82% -$4.12M 0.01% 1563
2020
Q4 		$4.14M Buy
29,231
+27,561
+1,650% +$4M 0.02% 605
2020
Q3 		$208K Buy
1,670
+101
+6% +$10.6K ﹤0.01% 2131
2020
Q2 		$140K Buy
+1,569
New +$122K ﹤0.01% 3139
2019
Q4 		– Sell
-4,029
Closed -$203K – 3445
2019
Q3 		$203K Buy
+4,029
New +$223K ﹤0.01% 2348

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's TXG Position: Q2 2026 in Review

SG Americas Securities increased its 10x Genomics (TXG) stake by 202% in Q2 2026, buying an estimated $2.02M and bringing the position to 115,208 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

SG Americas Securities first reported a position in TXG in Q3 2019 and has held it in 24 quarters since. The position peaked at $5.71M in Q2 2021. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • SG Americas Securities held 115,208 shares of 10x Genomics worth $4.42M as of Q2 2026.
  • SG Americas Securities bought 77,074 10x Genomics shares in Q2 2026, an estimated $2.02M.
  • 10x Genomics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1147 holding.
  • SG Americas Securities first reported a position in 10x Genomics in Q3 2019 and has held it in 24 quarters since.
  • SG Americas Securities's 10x Genomics position peaked at $5.71M in Q2 2021.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.